Lab Information
Nandini Dendukuri (PhD)
ScientistCentre for Outcomes Research and Evaluation
Department of Medicine (McGill)
Research Profile
http://www.nandinidendukuri.com/
Keywords
Bayesian inference • biostatistics • diagnostic tests • latents class models • technology assessmentResearch Interests
My research focuses on the development of methods in the area of evaluating diagnostic tests in the absence of a gold standard, meta-analysis of diagnostic test properties and Bayesian estimation of small proportions. I am also involved in a number of collaborative projects with researchers in technology assessment and epidemiology.Team Members
| Name | Position |
|---|
Latest Publications
- Kutcher, S. A., Dendukuri, N., Dandona, S., Nadeau, L. & Brophy, J. M. (2025). Ticagrelor Compared to Clopidogrel in Acute Coronary Syndromes trial (TC4): a Bayesian pragmatic cluster randomized controlled trial. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, vol. 197, p. E309-E318.
- Li, J., Dendukuri, N., Longtin, Y., Banz, A., Frenette, C., Gervais, P., Miller, M. A., Bourgault, A.--. M., Dawang, N. L. & Loo, V. G. (2025). Determination of the performance of a novel diagnostic test for Clostridioides difficile toxins A and B using latent class analysis. Journal of clinical microbiology, p. e0180724.
- Prosty, C., Le, M., Lu, Y., Khoury, L., Cormier, M., Cheng, M. P., Fowler, R., Murthy, S., Tsang, J. L., Lejtenyi, D., Ben-Shoshan, M., Rahme, E., Golchi, S., Dendukuri, N., Lee, T. C. & Netchiporouk, E. (2024). Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trial. Frontiers in medicine, vol. 11, p. 1437322.
- Verreault-Julien, L., Jahan, I., Dendukuri, N., Ybarra, L. F., Mansour, S., Matteau, A., Wijeysundera, H. C., Fung, A., Robinson, S., Paradis, J.-M., Nguyen, C. M. & Rinfret, S. (2025). Outcomes following antegrade-only versus retrograde chronic total occlusion percutaneous coronary intervention: insights from the CCTOP registry. The Journal of invasive cardiology, vol. 37.
- Couture, S., Frenette, C., Schiller, I., Alfaro, R., Dendukuri, N., Thirion, D., Longtin, Y. & Loo, V. G. (2024). The changing epidemiology of Clostridioides difficile infection and the NAP1/027 strain in two Québec hospitals: a 17-year time-series study. Antimicrobial stewardship & healthcare epidemiology : ASHE, vol. 4, p. e99.
- Le, M., Khoury, L., Lu, Y., Prosty, C., Cormier, M., Cheng, M. P., Fowler, R., Murthy, S., Tsang, J. L. Y., Ben-Shoshan, M., Rahme, E., Golchi, S., Dendukuri, N., Lee, T. C. & Netchiporouk, E. (2024). COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)-a Randomized Controlled Clinical Trial. Open forum infectious diseases, vol. 11, p. ofae102.
- Schober, T., Wong, K., DeLisle, G., Caya, C., Brendish, N. J., Clark, T. W., Dendukuri, N., Doan, Q., Fontela, P. S., Gore, G. C., Li, P., McGeer, A. J., Noël, K. C., Robinson, J. L., Suarthana, E. & Papenburg, J. (2024). Clinical Outcomes of Rapid Respiratory Virus Testing in Emergency Departments: A Systematic Review and Meta-Analysis. JAMA internal medicine, vol. 184, p. 528-536.
- Zhan, Y., Friedrich, M. G., Dendukuri, N., Lu, Y., Chetrit, M., Schiller, I., Joseph, L., Shaw, J. L., Chuang, M. L., Riffel, J. H., Manning, W. J. & Afilalo, J. (2024). Meta-Analysis of Normal Reference Values for Right and Left Ventricular Quantification by Cardiovascular Magnetic Resonance. Circulation. Cardiovascular imaging, vol. 17, p. e016090.
- Bezemer, J. M., Merckx, J., Freire Paspuel, B. P., Calvopiña, M., de Vries, H. J. C., Schallig, H. D. F. H., Leeflang, M. M. G. & Dendukuri, N. (2023). Diagnostic accuracy of qPCR and microscopy for cutaneous leishmaniasis in rural Ecuador: A Bayesian latent class analysis. PLoS neglected tropical diseases, vol. 17, p. e0011745.
- Sandal, S., Schiller, I., Dendukuri, N., Robert, J.-T., Katergi, K., Alam, A., Cantarovich, M., Fiore, J. F., Suri, R. S., Landsberg, D., Weber, C. & Fortin, M.-C. (2022). Identifying Modifiable System-Level Barriers to Living Donor Kidney Transplantation. Kidney international reports, vol. 7, p. 2410-2420.
See also
